COMMUNIQUÉS West-GlobeNewswire

Advantis Corp. Developing Own Brand of Edibles, CBD Product Lines
15/10/2018
NEWPORT BEACH, CA, Oct. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) revealed today that they have been developing its own brand of cannabis-infused edibles, Amster Edibles. [...]
Rafael Pharmaceuticals to Present at BIO Investor Forum 2018
15/10/2018
Newark, NJ, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Sanjeev Luther, President and Chief Executive Officer of Rafael Pharmaceuticals, Inc. will be presenting at the BIO Investor Forum 2018 in San Francisco on Thursday, October [...]
CBT Pharmaceuticals Awarded NIH Small Business Innovation Research Grant Towards Development of Combination Checkpoint Inhibition
15/10/2018
PLEASANTON, Calif. and HANGZHOU, China, Oct. 15, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company committed to becoming a leader in the discovery and [...]
Novo Nordisk A/S - Share repurchase programme
15/10/2018
Bagsværd, Denmark, 15 October 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Teladoc Health Appoints Care Delivery Expert Dr. Mark Smith to Board of Directors
15/10/2018
PURCHASE, NY, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, is pleased to announce, effective today, the appointment of Mark Douglas Smith, MD, MBA, to its board of [...]
Avadel Pharmaceuticals Presents Data for NOCTIVA at 2018 American Urogynecologic Society Annual Scientific Meeting
15/10/2018
Data demonstrate significant improvement in number of nights with one or no nocturic episodes and extended first uninterrupted sleep period in patients suffering from nocturia due to nocturnal polyuria DUBLIN, Ireland, [...]
VistaGen Therapeutics Appoints Dr. Michael Liebowitz to CNS Clinical and Regulatory Advisory Board in Preparation for Pivotal Phase 3 Development of PH94B as the First Rapid-Acting, On-Demand Treatment of Social Anxiety Disorder
15/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics Inc ( NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) [...]
Albireo Announces Research on Cholestatic Liver Diseases to be Presented at Major North American Liver Meetings
15/10/2018
Study results to be presented at NASPGHAN demonstrate reductions in bile acids and bilirubin are highly associated with decreased aggregate need for liver transplant in PFIC patients Findings to be presented by NAPPED [...]
Sharps Compliance Announces It Has Properly Processed and Treated More Than 2.7 Million Pounds of Unused Ultimate-User Medications
15/10/2018
Strong Supporter of DEA’s National Drug Take Back Day HOUSTON, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Sharps Compliance, Inc. (Nasdaq: SMED), a nationwide provider of management services for medical waste and unused [...]
Terra Tech Corp.’s Edible Garden Subsidiary to Exhibit at the Fresh Summit International Convention & Expo in Florida, October 18th – 20th
15/10/2018
IRVINE, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp . (OTCQX: TRTC), (“Terra Tech” or the “Company”) a vertically integrated cannabis-focused agriculture company, is pleased to announce that its subsidiary [...]
MedTainer Inc. Finalizing Distribution Deal With humble+fume Co.
15/10/2018
CORONA, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- MedTainer Inc. (MDTR-OTCMARKETS) announced today that they are in the final stages of negotiations with Manitoba based Humble+fume to distribute its signature product, [...]
SELLAS to Host Conference Call Following Oral Presentation of Phase 2b Results of NeuVax™ + Herceptin® to Prevent Breast Cancer Recurrence at the European Society for Medical Oncology (ESMO) 2018 Annual Meeting
15/10/2018
Interim and Updated Final Clinical Data to be Presented Conference Call on October 22, 2018 at 8:00 a.m. ET NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or the “ [...]
Advanced Proteome Therapeutics Reports Progress on Collaboration with Noria Pharmaceuticals
15/10/2018
VANCOUVER, British Columbia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) , is pleased to announce the successful completion of the first [...]
Organovo to Present New Preclinical Data on 3D Bioprinted Human Liver Tissues for the Treatment of Tyrosinemia I at the Liver Meeting® 2018 (AASLD)
15/10/2018
SAN DIEGO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and [...]
Allscripts strengthens payer and life sciences’ focus and talent, expands capabilities
15/10/2018
Company brings together life science industry experts to accelerate growth and focus on Late-Phase Clinical Research, Real-World Evidence data and analytics solutions CHICAGO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Today, [...]
Matinas BioPharma Appoints Global Pharmaceutical Drug Development Industry Leader Theresa Matkovits, Ph.D., Chief Development Officer; Further Expands Manufacturing and Clinical Development Team
15/10/2018
- Dr. Matkovits is an industry leader with 20+ years of proven global drug development success bringing 4 approved medicines to several global markets - - Frank Calamusa, CSCP, an established biotech CMC leader with 20 [...]
athenahealth Announces Third Quarter 2018 Earnings Conference Call
15/10/2018
WATERTOWN, Mass., Oct. 15, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ:ATHN), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that it will hold a [...]
Galectin Therapeutics to Present at The ROTH Capital Battle of the NASH Thrones Investment Conference
15/10/2018
NORCROSS, Ga., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that management will participate in the [...]
Daré Bioscience, Inc. to Present an Overview of Novel Intra-Vaginal Ring (IVR) Technologies at the Partnership Opportunities in Drug Delivery (PODD) Meeting Held in Boston, MA October 17th – 18th
15/10/2018
SAN DIEGO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a clinical-stage, women’s health-focused biopharmaceutical company, today announced it will be presenting scientific and technical [...]

Pages